Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 1 Patient and disease characteristics of 46 patients with paranasal sinus carcinomas treated with IMRT

From: Intensity modulated radiotherapy (IMRT) in patients with carcinomas of the paranasal sinuses: clinical benefit for complex shaped target volumes

 

N (%)

Gender

 

female

18 (39%)

male

28 (61%)

Histology

 

Adenocarcinoma

8 (17.4%)

Squamous Cell Carcinoma

6 (13%)

Adenoid-cystic Carcinoma

20 (43.4%)

Melanoma

8 (17.4%)

other

4 (8.8%)

Primary tumor site

 

Maxillary sinus

22 (47.8%)

Ethmoidal sinus

4 (8.7%)

Sphenoid sinus

4 (8.7%)

Nasal cavity

16 (34.8%)

Tumor stage

 

T1

2 (4%)

T2

3 (7%)

T3

11 (24%)

T4

30 (65%)

Nodal stage

 

N0

34 (74%)

N1

6 (13%)

N2

1 (2%)

Nx

5 (11%)

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us